The Brain Health Registry: An internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies-Reference-Cited by-同舟云学术

The Brain Health Registry: An internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies

Published:2018-05-10 Issue:8 Volume:14 Page:1063-1076
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Weiner Michael W.¹²³⁴⁵,Nosheny Rachel¹⁴,Camacho Monica¹²⁶,Truran‐Sacrey Diana¹⁶,Mackin R. Scott¹⁴,Flenniken Derek¹²⁶,Ulbricht Aaron¹²,Insel Philip¹⁶,Finley Shannon¹⁶,Fockler Juliet¹²,Veitch Dallas¹⁶

Affiliation:

1. Department of Veterans Affairs Medical CenterCenter for Imaging and Neurodegenerative DiseasesSan FranciscoCAUSA

2. Department of Radiology and Biomedical ImagingUniversity of CaliforniaSan FranciscoCAUSA

3. Department of MedicineUniversity of California San FranciscoSan FranciscoCAUSA

4. Department of PsychiatryUniversity of California San FranciscoSan FranciscoCAUSA

5. Department of NeurologyUniversity of California San FranciscoSan FranciscoCAUSA

6. Northern California Institute for Research and Education (NCIRE)Department of Veterans Affairs Medical CenterSan FranciscoCAUSA

Funder

California Department of Public Health

Alzheimer's Association

Alzheimer's Drug Discovery Foundation

Larry L. Hillblom Foundation

Janssen Pharmaceuticals

Monell Chemical Senses, Patient Centered Outcomes Research Institute

VU University Medical Center, Janssen Pharmaceutica, and Biogen, Inc

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2018.02.021

Reference31 articles.

1. 2016 Alzheimer's disease facts and figures

2. Alzheimer's Disease Facts and Figures;Association A.S.;Alzheimers Dement,2015

3. The A4 Study: Stopping AD Before Symptoms Begin?

4. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

5. Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of self‐ or parent‐reported psychiatric phenotypes in longitudinal studies;Journal of Child Psychology and Psychiatry;2024-09-09

2. Storyteller in ADNI4: Application of an early Alzheimer's disease screening tool using brief, remote, and speech‐based testing;Alzheimer's & Dementia;2024-09-05

3. The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research;Alzheimer's & Dementia;2024-09

4. Perception of Computer Cognitive Test Among Users and Clinical Observers;2024-08-09

5. Mobile toolbox (MTB) remote measures of executive function and processing speed: development and validation;Journal of the International Neuropsychological Society;2024-07-11